Search company, investor...
Phost'In Therapeutics company logo

Phost'In Therapeutics

phostin.com

Founded Year

2014

Stage

Series A | Alive

Total Raised

$11.16M

Last Raised

$11.16M | 3 yrs ago

About Phost'In Therapeutics

Phost'In Therapeutics is a biopharmaceutical company focused on the discovery and development of N-glycosylation inhibitors. The firm develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response.

Headquarters Location

104 rue de la Galera

Montpellier, 34 090,

France

Missing: Phost'In Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Phost'In Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Phost'In Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Phost'In Therapeutics is included in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Phost'In Therapeutics Patents

Phost'In Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Chemical processes
  • Chromatography
  • Fluoroarenes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/19/2017

3/24/2020

Pharmaceutical industry, Polymers, Chemical processes, Fluoroarenes, Chromatography

Grant

Application Date

9/19/2017

Grant Date

3/24/2020

Title

Related Topics

Pharmaceutical industry, Polymers, Chemical processes, Fluoroarenes, Chromatography

Status

Grant

Phost'In Therapeutics Frequently Asked Questions (FAQ)

  • When was Phost'In Therapeutics founded?

    Phost'In Therapeutics was founded in 2014.

  • Where is Phost'In Therapeutics's headquarters?

    Phost'In Therapeutics's headquarters is located at 104 rue de la Galera, Montpellier.

  • What is Phost'In Therapeutics's latest funding round?

    Phost'In Therapeutics's latest funding round is Series A.

  • How much did Phost'In Therapeutics raise?

    Phost'In Therapeutics raised a total of $11.16M.

  • Who are the investors of Phost'In Therapeutics?

    Investors of Phost'In Therapeutics include ANRI, Remiges Ventures and IRDI SORIDEC Gestion.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.